Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
University of Colorado, DenverNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingBreast Cancer FemaleUnited States
-
MGH Institute of Health ProfessionsNational Cancer Institute (NCI)Completed
-
University of VirginiaSyndax PharmaceuticalsCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Peregrine PharmaceuticalsWithdrawnMetastatic Breast CancerUnited States
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
Indiana UniversityNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
University of WashingtonRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States
-
Mayo ClinicRecruitingBreast CarcinomaUnited States
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterWithdrawnMetastatic Breast CancerUnited States
-
Carilion ClinicCompletedBreast Reconstruction | Breast ReductionUnited States
-
Mayo ClinicRecruitingHER2-Negative Breast Carcinoma | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedNeoplasm Metastasis | Breast NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Lobular Carcinoma In Situ | Breast Sclerosing AdenosisUnited States
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Breast CancerUnited States
-
NorthShore University HealthSystemNorthwestern UniversityCompletedBreast Cancer | SurgeryUnited States
-
University of VermontCompletedBreast Cancer | AngiogenesisUnited States
-
M.D. Anderson Cancer CenterCompleted
-
University of PittsburghCompletedBreast Cancer | MastectomyUnited States
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
CelgeneTerminatedStage IV (Metastatic) Breast CancerUnited States
-
University of UtahCelgene CorporationTerminatedStages II-III Breast CancerUnited States
-
Cancer Research NetworkSanofiUnknown
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedAdvanced Breast Cancer Stage IVUnited States
-
University of PittsburghCompletedBreast Cancer Survivor | Cancer Related FatigueUnited States
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedGynecologic Cancer | Breast CancersUnited States
-
Mercy Medical CenterSusan G. Komen Breast Cancer FoundationCompletedFatigue After Adjuvant Breast Cancer TreatmentUnited States
-
Pravin T.P KaumayaRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
Massachusetts General HospitalTesaro, Inc.Active, not recruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
University of MiamiNational Cancer Institute (NCI)Not yet recruitingBreast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of Health; Florida Biomedical Research Program - Bankhead...Recruiting
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Cardiotoxicity | Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | HER2-positive Metastatic Breast CancerUnited States
-
University of California, San FranciscoRecruitingCardiovascular Diseases | Breast CancerUnited States
-
University of South CarolinaUniversity of Colorado, Denver; Brown University; InquisitHealth, Inc.Active, not recruiting
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Breast... and other collaboratorsTerminatedTriple Negative Breast NeoplasmsUnited States
-
University of California, San DiegoNational Cancer Institute (NCI)CompletedBreast Cancer | Physical ActivityUnited States
-
Yale UniversityCompletedBreast CancerUnited States
-
University of RochesterRecruitingBreast Cancer Female | Cancer Related Cognitive DifficultiesUnited States
-
Carol Fabian, MDCompletedIncreased Risk for Development of Breast CancerUnited States
-
University of RochesterCompletedBreast Cancer, MetastaticUnited States
-
University of Michigan Rogel Cancer CenterCompletedMetastatic Breast CancerUnited States
-
Washington University School of MedicineCompleted
-
University of WashingtonBreast Cancer Research FoundationRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
Steven J Isakoff, MD, PhDDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AbbottCompletedBreast Cancer | Metastatic Breast Cancer | BRCA1 Gene Mutation | brca2 Gene MutationUnited States